Guillain-Barré Syndrome underlying SARS-CoV-2 or just a confounding factor?
DOI:
https://doi.org/10.25751/rspa.20626Keywords:
Guillain-Barré syndrome, SARS-CoV-2, Covid-19, Mechanical VentilationAbstract
Guillain-Barré syndrome was frequently associated with a viral infection. Molecular mimicry is one of the mechanisms through which viruses can be involved in the etiology of this inflammatory demyelinating neuropathy. We describe a case of a 58-year-old man with a diagnosis of SARS-CoV-2 infection who developed clinical symptoms which are coincident with Guillain-Barré syndrome. SARS-CoV-2 could have been the trigger and even though the causative relationship remains unclear, there is a probable cause-effect association between SARS-CoV-2 and GBS, however more studies are needed to support this association.
Downloads
References
2. Ahmed Virani, Erica Rabold, Taylor Hanson, Aaron Haag, Rawiya Elrufay, Tariq Cheema, Marvin Balaan, Nitin Bhanot. Guillain-Barré Syndrome associated with SARS-CoV2 infection. Elsevier 12 April 2020 https://doi.org/10.1016/j.idcr.2020.e00771
3. Gianpaolo Toscano, Francesco Palmerini, Sabrina Ravaglia, Luigi Ruiz, Paolo Invernizzi, M. Giovanna Cuzzoni et al. Guillain-Barré Syndrome associated with SARS-CoV2 infection. N Engl J Med. April 17, 2020. DOI: 10.1056/NEJMc2009191
4. Aggarwal A N, Gupta D, Lal V, Behera D, Jindal S K, Prabhakar S. Ventilatory management of respiratory failure in patients with severe Guillain-Barré syndrome. Neurol India 2003;51:203-205. http://www.neurologyindia.com/text.asp?2003/51/2/203/1083
5. Hua Zhao, Dingding Shen, Haiyan Zhou, Jun Liu, Sheng Chen. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? The Lancet . Vol 19 May 2020 https://doi.org/10.1016/S1474-4422(20)30109-5
Downloads
Published
How to Cite
Issue
Section
License
Articles are freely available to be read, downloaded and shared from the time of publication.
The RSPA reserves the right to commercialize the article as an integral part of the journal (in the preparation of reprints, for example). The author should accompany the submission letter with a declaration of copyright transfer for commercial purposes.
Articles are published under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC).
After publication in RSPA, authors are allowed to make their articles available in repositories of their home institutions, as long as they always mention where they were published.